Opal Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Sell |
3,116
-562
| -15% | -$38.8K | 0.06% | 183 |
|
|
2025
Q1 | $255K | Sell |
3,678
-455
| -11% | -$31.6K | 0.08% | 143 |
|
|
2024
Q4 | $356K | Buy |
4,133
+962
| +30% | +$82.7K | 0.11% | 116 |
|
|
2024
Q3 | $378K | Buy |
3,171
+418
| +15% | +$49.8K | 0.12% | 103 |
|
|
2024
Q2 | $393K | Sell |
2,753
-254
| -8% | -$36.3K | 0.13% | 93 |
|
|
2024
Q1 | $386K | Buy |
3,007
+7
| +0.2% | +$899 | 0.13% | 105 |
|
|
2023
Q4 | $310K | Sell |
3,000
-14
| -0.5% | -$1.45K | 0.12% | 125 |
|
|
2023
Q3 | $274K | Buy |
3,014
+468
| +18% | +$42.6K | 0.16% | 111 |
|
|
2023
Q2 | $206K | Sell |
2,546
-148
| -5% | -$12K | 0.1% | 138 |
|
|
2023
Q1 | $214K | Sell |
2,694
-788
| -23% | -$62.7K | 0.13% | 105 |
|
|
2022
Q4 | $236K | Buy |
+3,482
| New | +$236K | 0.13% | 100 |
|